Dr. Patel’s postdoctoral research looked at developing community-based public health interventions that improve HIV care for injection drug users in Ottawa, under the leadership of her supervisor Dr. Mark Tyndall, the director of British Columbia’s Center for Disease Control.
“Despite major advances in antiretroviral therapy (ART), the uptake and retention of ART remains elusive for many, particularly for vulnerable populations like injection drug users IDUs),” says Dr. Patel. “This highlights the need for more effective and targeted community-based models of HIV care and treatment delivery.”
The overall aim of Dr. Patel’s project was to reduce the risk of HIV infection and improve HIV care among IDUs in Ottawa.
Dr. Patel currently works at Genentech, a biotechnology corporation, as an associate scientist. She previously worked for the Centre for Health Evaluation and Outcome Sciences – a health outcomes research organization based in St. Paul’s Hospital, Vancouver, and also holds a PhD in Healthcare and Epidemiology.